Insights from 2023 ESMO Asia Annual Meeting

 

Insights from 2023 ESMO Asia Annual Meeting
M

ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, When, and Who"

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Masahiro Tsuboi
By Insights from 2023 ESMO Asia Annual Meeting FEATURING Masahiro Tsuboi
53 views
January 3, 2024
0 Comments
Login to view comments. Click here to Login
Lung
10:08

Oncogene-Driven NSCLC: RET, NTRK, and ROS1

Insights from 2023 ESMO Asia Annual Meeting

J. Tanizaki

405 views
09:17

ESMO Asia 2023 Summary: "Befotertinib, Osimertinib, Telisotuzumab Ve…

Insights from 2023 ESMO Asia Annual Meeting

J. Tanizaki

88 views
06:58

ESMO Asia 2023 Insights: "Efficacy & Safety of MCLA-129, an Anti-EGF…

Insights from 2023 ESMO Asia Annual Meeting

M. Brandão

82 views
06:57

ESMO Asia 2023 Insights: "TROPION-Lung01 Study - Dato-DXd vs. Doceta…

Insights from 2023 ESMO Asia Annual Meeting

M. Ahn

111 views
06:45

ESMO Asia 2023 Insights: "DeLLphi-301 Study - Tarlatamab for Patient…

Insights from 2023 ESMO Asia Annual Meeting

M. Ahn

158 views
13:20

ESMO Asia 2023 Insights: "EGFR TKIs in NSCLC - Which One, How Long, …

Insights from 2023 ESMO Asia Annual Meeting

M. Tsuboi

53 views